BML Funding Partners, L.P. Points an Originate Letter to Shareholders

Zionsville, IN, February 25, 2025 –(PR.com)– BML Funding Partners, L.P. issues an originate letter to shareholders:

“Shareholders of Aadi Bioscience
17383 Sundown Blvd., Suite A259
Pacific Palisades, CA 90272

Dear Shareholders,

BML Funding Partners, L.P. and Braden M. Leonard, collectively a functional holder of two.435 million AADI shares, or 9.9% of total outstanding, is voting NO to all of the February 28 proposals and suggests other shareholders enact the same.

Primarily the most contemporary proposals enact NOT maximize label, and BML believes shareholders are lots higher served if the Board pursues Kraken’s prior provide to buy all the company for what would seemingly amount to over $5 per fragment. Right here’s clearly a higher deal for shareholders than a 60% dilution at $2.40, which is what they’re asking us to approve on February twenty eighth.

For an intensive clarification of the proposals recommend by the AADI Board, and why they’re a shocking deal for shareholders, please gaze BML’s Originate Letter to Shareholders here.

Sincerely,
BML Capital Management, LLC”